Keywords: Novartis, Valturna, Renin inhibitors, FDA approval

FDA OK for Novartis’ Valturna has significant implications, say Zacks analysts

Article | 20 September 2009

• Print This

The US Food and Drug Administration recently approved Swiss drug major Novartis’ Valturna for high blood pressure. The drug is ...

Enjoying this article? To continue reading you need to login or subscribe.